OGN
Organon & Co.
NYSE · USHealthcareDrug Manufacturers - General
$13.49-0.22%
Price as of Jul 20, 2026
OGN profitability
Organon & Co. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 53.1%
- EBITDA margin
- 22.4%
- EBIT margin
- 19.2%
- Net margin
- 4.0%
- Free cash flow margin
- 10.0%
Returns
- Return on equity
- 27.2%
- Return on assets
- 1.9%
- Return on invested capital
- 12.5%
- Asset turnover
- 0.48x
Cash efficiency
- Cash from operations
- $850.0M
- Cash per share
- $4.25
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.